AGP Executive Report
Last update: 12 hours agoTB Progress: India says TB deaths have fallen 38% since 2015, with treatment success at 94%. Globally, WHO reports 1.13 million TB deaths in 2025 and warns funding cuts could threaten further gains. Cell and Gene Therapy: New FDA potency guidance gives developers clearer direction on testing and manufacturing controls. Obesity Drugs: Pfizer secured up to $1.5 billion from Blackstone to help fund trials of its long-acting GLP-1 candidate berobenatide. Drug Manufacturing: Ghana plans a $1 billion investment in pharmaceutical and biomanufacturing hubs from 2027, aiming to reduce reliance on imports. AI in Care: More than half of surveyed US physicians say they use AI daily; many use it for clinical decisions and literature searches, though concerns remain about effects on trainee skills. Maternal and Infant Health: A study found congenital syphilis rates among US newborns rose nearly sixfold from 2012 to 2022, with the steepest increase among Native American babies.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
